✦ LIBER ✦

Intraperitoneal α-Interferon Alternating with Cisplatin in Residual Ovarian Carcinoma: A Phase II Gynecologic Oncology Group Study

✍ Scribed by Jonathan S. Berek; Maurie Markman; John A. Blessing; Paul R. Kucera; Beth E. Nelson; Barrie Anderson; Parviz Hanjani

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intraperitoneal Interferon-α in Residual

✍ Jonathan S. Berek; Maurie Markman; Bette Stonebraker; Samuel S. Lentz; Mark D. A 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 45 KB

A Phase II Study of Intraperitoneal Cisp

✍ Lynn G. Feun; John A. Blessing; Francis J. Major; Philip J. DiSaia; Ronald D. Al 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Intraperitoneal Administration of Cispla

✍ Patricia S. Braly; Jonathan S. Berek; John A. Blessing; Howard D. Homesley; Herv 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 322 KB

Phase I feasibility study of intraperito

✍ Don S. Dizon; Michael W. Sill; Natalie Gould; Stephen C. Rubin; S. Diane Yamada; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 162 KB

A phase II study of docetaxel in paclita

✍ Peter G Rose; John A Blessing; Harrison G Ball; James Hoffman; David Warshal; Ko 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Characteristics of patients with small-v

✍ Maurie Markman; Jonathan S. Berek; John A. Blessing; William P. McGuire; Jeffrey 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 675 KB